261 related articles for article (PubMed ID: 15194923)
21. Model results of kidney burdens from uranium intakes.
Chen J; Meyerhof DP; Tracy BL
Health Phys; 2004 Jan; 86(1):3-11. PubMed ID: 14695003
[TBL] [Abstract][Full Text] [Related]
22. Leukemia among uranium miners--late effects of exposure to uranium dust?
Tomasek L
Health Phys; 2004 Apr; 86(4):426-7. PubMed ID: 15057066
[No Abstract] [Full Text] [Related]
23. Capstone depleted uranium aerosol biokinetics, concentrations, and doses.
Guilmette RA; Miller G; Parkhurst MA
Health Phys; 2009 Mar; 96(3):328-42. PubMed ID: 19204489
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the effect of implanted depleted uranium (DU) on adult rat behavior and toxicological endpoints.
Arfsten DP; Wilfong ER; Bekkedal MY; Johnson EW; McInturf SM; Eggers JS; Schaeffer DJ; Still KR
J Toxicol Environ Health A; 2007 Dec; 70(23):1995-2010. PubMed ID: 17966071
[TBL] [Abstract][Full Text] [Related]
25. Leaching of depleted uranium in soil as determined by column experiments.
Schimmack W; Gerstmann U; Oeh U; Schultz W; Schramel P
Radiat Environ Biophys; 2005 Dec; 44(3):183-91. PubMed ID: 16208523
[TBL] [Abstract][Full Text] [Related]
26. Undiagnosed illnesses and radioactive warfare.
Duraković A
Croat Med J; 2003 Oct; 44(5):520-32. PubMed ID: 14515407
[TBL] [Abstract][Full Text] [Related]
27. Clinical diagnostic indicators of renal and bone damage in rats intramuscularly injected with depleted uranium.
Fukuda S; Ikeda M; Chiba M; Kaneko K
Radiat Prot Dosimetry; 2006; 118(3):307-14. PubMed ID: 16436523
[TBL] [Abstract][Full Text] [Related]
28. Acute toxicity of subcutaneously administered depleted uranium and the effects of CBMIDA in the simulated wounds of rats.
Fukuda S; Ikeda M; Nakamura M; Yan X; Xie Y
Health Phys; 2009 Apr; 96(4):483-92. PubMed ID: 19276709
[TBL] [Abstract][Full Text] [Related]
29. Oxidation states of uranium in DU particles from Kosovo.
Salbu B; Janssens K; Lind OC; Proost K; Danesi PR
J Environ Radioact; 2003; 64(2-3):167-73. PubMed ID: 12500803
[TBL] [Abstract][Full Text] [Related]
30. Physicochemical characterization of Capstone depleted uranium aerosols II: particle size distributions as a function of time.
Cheng YS; Kenoyer JL; Guilmette RA; Parkhurst MA
Health Phys; 2009 Mar; 96(3):266-75. PubMed ID: 19204485
[TBL] [Abstract][Full Text] [Related]
31. Distribution of uranium in rats implanted with depleted uranium pellets.
Pellmar TC; Fuciarelli AF; Ejnik JW; Hamilton M; Hogan J; Strocko S; Emond C; Mottaz HM; Landauer MR
Toxicol Sci; 1999 May; 49(1):29-39. PubMed ID: 10367339
[TBL] [Abstract][Full Text] [Related]
32. Physicochemical characterization of Capstone depleted uranium aerosols IV: in vitro solubility analysis.
Guilmette RA; Cheng YS
Health Phys; 2009 Mar; 96(3):292-305. PubMed ID: 19204487
[TBL] [Abstract][Full Text] [Related]
33. Optimising monitoring regimens for inhaled uranium oxides.
Stradling N; Hodgson A; Ansoborlo E; Bérard P; Etherington G; Fell T; LeGuen B
Radiat Prot Dosimetry; 2003; 105(1-4):109-14. PubMed ID: 14526938
[TBL] [Abstract][Full Text] [Related]
34. Aerosol sampling system for collection of Capstone depleted uranium particles in a high-energy environment.
Holmes TD; Guilmette RA; Cheng YS; Parkhurst MA; Hoover MD
Health Phys; 2009 Mar; 96(3):221-37. PubMed ID: 19204482
[TBL] [Abstract][Full Text] [Related]
35. Comparison of absorption after inhalation and instillation of uranium octoxide.
Pellow PG; Hodgson SA; Hodgson A; Rance E; Ellender M; Guilmette RA; Stradling GN
Radiat Prot Dosimetry; 2003; 105(1-4):105-8. PubMed ID: 14526937
[TBL] [Abstract][Full Text] [Related]
36. Microanalytical X-ray imaging of depleted uranium speciation in environmentally aged munitions residues.
Crean DE; Livens FR; Stennett MC; Grolimund D; Borca CN; Hyatt NC
Environ Sci Technol; 2014; 48(3):1467-74. PubMed ID: 24451034
[TBL] [Abstract][Full Text] [Related]
37. Long term depleted uranium exposure in Gulf War I veterans does not cause elevated numbers of micronuclei in peripheral blood lymphocytes.
Bakhmutsky MV; Oliver MS; McDiarmid MA; Squibb KS; Tucker JD
Mutat Res; 2011 Feb; 720(1-2):53-7. PubMed ID: 21167307
[TBL] [Abstract][Full Text] [Related]
38. The effects of the initial lung deposit on uranium biokinetics after administration as UF4 and UO4.
Houpert P; Chazel V; Paquet F; Henge-Napoli MH; Ansoborlo E
Int J Radiat Biol; 1999 Mar; 75(3):373-7. PubMed ID: 10203187
[TBL] [Abstract][Full Text] [Related]
39. Effective dose scaling factors for use with uranium series cascade impactor data: a reassessment using the IMBA code.
Kim KP; Wu CY; Birky BK; Bolch WE
Health Phys; 2006 Oct; 91(4):331-7. PubMed ID: 16966876
[TBL] [Abstract][Full Text] [Related]
40. A study of uranium lung clearance at a uranium processing plant.
Barber JM; Forrest RD
Health Phys; 1995 May; 68(5):661-9. PubMed ID: 7730062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
